コーパス検索結果 (right1)
通し番号をクリックするとPubMedの該当ページを表示します
1 eived volasertib and 55 received chemotherapy; demographics were well balanced.
2 Other characteristics were well balanced.
3 Baseline characteristics between groups were well balanced.
4 Demographic and baseline clinical characteristics were well balanced.
5 s were developed, each with 1:1 matching to controls, which were well balanced.
6 demographic and clinical characteristics between the groups were well balanced.
7 Baseline characteristics were well balanced.
8 The palifermin (n = 94) and placebo (n = 94) arms were well balanced.
9 67 to placebo) were evaluable, and baseline characteristics were well balanced.
10 BMS-treated groups whose observed baseline characteristics were well-balanced.
15 n=22 830) and other glucose-lowering drug (n=68 490) groups were well balanced at baseline, with a mean follow-up of 0.9
22 exception of prior BRAF inhibitor therapy, the demographics were well balanced between the 2 cohorts.
24 Patient demographic and baseline characteristics were well balanced between the 2 treatment groups.
26 variation in indications for GPIs, baseline characteristics were well balanced between the cangrelor and clopidogrel arms
35 After propensity matching, 367 unique pairs were well balanced in terms of all measured covariates.
39 Baseline clinical and QOL variables were well balanced in the 451 patients randomized to chelatio
40 between percutaneous coronary intervention and CABG groups were well-balanced, including urgent revascularization priori
41 ing resulted in cohorts of SG, RYGB, and LAGB patients that were well balanced on baseline characteristics.
42 The baseline characteristics of the participants were well balanced, the mean age was 62.5 years, 66% of parti
43 In 189 randomly assigned patients, treatment arms were well balanced with regard to clinical characteristics.
44 Participants enrolled in each cohort were well balanced with respect to age and presence of underl
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。